Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanna Ko

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Meta-analysis: Persistence of advanced therapies in the treatment of inflammatory bowel diseaseTsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Alimentary Pharmacology & Therapeutics|May 23, 2024
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' replyTsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Expert Opinion on Drug Safety|November 13, 2015
Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanismsYanna Ko, James Tang, Santosh Sanagapalli, et al.
The American Journal of Gastroenterology|January 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) StudyJohn David Chetwood, Yanna Ko, Aviv Pudipeddi, et al.
Journal of Crohn'S & Colitis|March 26, 2014
Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitisRupert W L Leong, Tony Huang, Yanna Ko, et al.
Methods and Protocols|August 27, 2025
The Effect of Faecal Microbiota Transplantation on Cognitive Function in Cognitively Healthy Adults with Irritable Bowel Syndrome: Protocol for a Randomised, Placebo-Controlled, Double-Blinded Pilot StudySara Alaeddin, Yanna Ko, Genevieve Z Steiner-Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2015
Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to AustraliaYanna Ko, Viraj Kariyawasam, Mohamad Karnib, et al.
Intestinal Research|August 10, 2018
The association between new generation oral contraceptive pill and the development of inflammatory bowel diseasesSantosh Sanagapalli, Yanna Ko, Viraj Kariyawasam, et al.
Journal of Clinical Immunology|September 17, 2018
Gastric Cancer Screening in Common Variable ImmunodeficiencyDavid K van der Poorten, Duncan McLeod, Golo Ahlenstiel, et al.
Gut|September 14, 2014
Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-PacificSiew C Ng, Whitney Tang, Rupert W Leong, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Meta-analysis: Persistence of advanced therapies in the treatment of inflammatory bowel diseaseTsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Alimentary Pharmacology & Therapeutics|May 23, 2024
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' replyTsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Expert Opinion on Drug Safety|November 13, 2015
Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanismsYanna Ko, James Tang, Santosh Sanagapalli, et al.
The American Journal of Gastroenterology|January 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) StudyJohn David Chetwood, Yanna Ko, Aviv Pudipeddi, et al.
Journal of Crohn'S & Colitis|March 26, 2014
Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitisRupert W L Leong, Tony Huang, Yanna Ko, et al.
Methods and Protocols|August 27, 2025
The Effect of Faecal Microbiota Transplantation on Cognitive Function in Cognitively Healthy Adults with Irritable Bowel Syndrome: Protocol for a Randomised, Placebo-Controlled, Double-Blinded Pilot StudySara Alaeddin, Yanna Ko, Genevieve Z Steiner-Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2015
Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to AustraliaYanna Ko, Viraj Kariyawasam, Mohamad Karnib, et al.
Intestinal Research|August 10, 2018
The association between new generation oral contraceptive pill and the development of inflammatory bowel diseasesSantosh Sanagapalli, Yanna Ko, Viraj Kariyawasam, et al.
Journal of Clinical Immunology|September 17, 2018
Gastric Cancer Screening in Common Variable ImmunodeficiencyDavid K van der Poorten, Duncan McLeod, Golo Ahlenstiel, et al.
Gut|September 14, 2014
Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-PacificSiew C Ng, Whitney Tang, Rupert W Leong, et al.
Pageof 2